The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Ankylosing Spondylitis Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture. The prevalence of ankylosing spondylitis is seen in about 0.1% to 0.5% of the adult population worldwide. It can occur at any age irrespective of gender; however, higher prevalence has been observed among males between the ages of 15–30 years.
The global Ankylosing Spondylitis Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ankylosing Spondylitis Treatment in various end use industries. The expanding demands from the Juveniles and Adults, are propelling Ankylosing Spondylitis Treatment market. Disease-Modifying Anitrheumatic Drugs (DMARDs), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ankylosing Spondylitis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ankylosing Spondylitis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ankylosing Spondylitis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ankylosing Spondylitis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ankylosing Spondylitis Treatment covered in this report include Abbvie, Amgen, Janssen Biotech, Merck, UCB, Boehringer Ingelheim and Johnson & Johnson, etc.
The global Ankylosing Spondylitis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbvie
Amgen
Janssen Biotech
Merck
UCB
Boehringer Ingelheim
Johnson & Johnson
Global Ankylosing Spondylitis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ankylosing Spondylitis Treatment market, Segment by Type:
Disease-Modifying Anitrheumatic Drugs (DMARDs)
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Biologics
Global Ankylosing Spondylitis Treatment market, by Application
Juveniles
Adults
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Ankylosing Spondylitis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture. The prevalence of ankylosing spondylitis is seen in about 0.1% to 0.5% of the adult population worldwide. It can occur at any age irrespective of gender; however, higher prevalence has been observed among males between the ages of 15–30 years.
The global Ankylosing Spondylitis Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ankylosing Spondylitis Treatment in various end use industries. The expanding demands from the Juveniles and Adults, are propelling Ankylosing Spondylitis Treatment market. Disease-Modifying Anitrheumatic Drugs (DMARDs), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ankylosing Spondylitis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ankylosing Spondylitis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ankylosing Spondylitis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ankylosing Spondylitis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ankylosing Spondylitis Treatment covered in this report include Abbvie, Amgen, Janssen Biotech, Merck, UCB, Boehringer Ingelheim and Johnson & Johnson, etc.
The global Ankylosing Spondylitis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbvie
Amgen
Janssen Biotech
Merck
UCB
Boehringer Ingelheim
Johnson & Johnson
Global Ankylosing Spondylitis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ankylosing Spondylitis Treatment market, Segment by Type:
Disease-Modifying Anitrheumatic Drugs (DMARDs)
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Biologics
Global Ankylosing Spondylitis Treatment market, by Application
Juveniles
Adults
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Ankylosing Spondylitis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Ankylosing Spondylitis Treatment
1.1 Ankylosing Spondylitis Treatment Market Overview
1.1.1 Ankylosing Spondylitis Treatment Product Scope
1.1.2 Ankylosing Spondylitis Treatment Market Status and Outlook
1.2 Global Ankylosing Spondylitis Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Ankylosing Spondylitis Treatment Market Size by Region (2018-2029)
1.4 Global Ankylosing Spondylitis Treatment Historic Market Size by Region (2018-2023)
1.5 Global Ankylosing Spondylitis Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Ankylosing Spondylitis Treatment Market Size (2018-2029)
1.6.1 North America Ankylosing Spondylitis Treatment Market Size (2018-2029)
1.6.2 Europe Ankylosing Spondylitis Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Ankylosing Spondylitis Treatment Market Size (2018-2029)
1.6.4 Latin America Ankylosing Spondylitis Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Ankylosing Spondylitis Treatment Market Size (2018-2029)
2 Ankylosing Spondylitis Treatment Market by Type
2.1 Introduction
2.1.1 Disease-Modifying Anitrheumatic Drugs (DMARDs)
2.1.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
2.1.3 Biologics
2.2 Global Ankylosing Spondylitis Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Ankylosing Spondylitis Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Ankylosing Spondylitis Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Ankylosing Spondylitis Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Ankylosing Spondylitis Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Ankylosing Spondylitis Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Ankylosing Spondylitis Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Ankylosing Spondylitis Treatment Revenue Breakdown by Type (2018-2029)
3 Ankylosing Spondylitis Treatment Market Overview by Application
3.1 Introduction
3.1.1 Juveniles
3.1.2 Adults
3.2 Global Ankylosing Spondylitis Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Ankylosing Spondylitis Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Ankylosing Spondylitis Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Ankylosing Spondylitis Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Ankylosing Spondylitis Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Ankylosing Spondylitis Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Ankylosing Spondylitis Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Ankylosing Spondylitis Treatment Revenue Breakdown by Application (2018-2029)
4 Ankylosing Spondylitis Treatment Competition Analysis by Players
4.1 Global Ankylosing Spondylitis Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ankylosing Spondylitis Treatment as of 2022)
4.3 Date of Key Players Enter into Ankylosing Spondylitis Treatment Market
4.4 Global Top Players Ankylosing Spondylitis Treatment Headquarters and Area Served
4.5 Key Players Ankylosing Spondylitis Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Ankylosing Spondylitis Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbvie
5.1.1 Abbvie Profile
5.1.2 Abbvie Main Business
5.1.3 Abbvie Ankylosing Spondylitis Treatment Products, Services and Solutions
5.1.4 Abbvie Ankylosing Spondylitis Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Abbvie Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Ankylosing Spondylitis Treatment Products, Services and Solutions
5.2.4 Amgen Ankylosing Spondylitis Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Amgen Recent Developments
5.3 Janssen Biotech
5.3.1 Janssen Biotech Profile
5.3.2 Janssen Biotech Main Business
5.3.3 Janssen Biotech Ankylosing Spondylitis Treatment Products, Services and Solutions
5.3.4 Janssen Biotech Ankylosing Spondylitis Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Ankylosing Spondylitis Treatment Products, Services and Solutions
5.4.4 Merck Ankylosing Spondylitis Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 UCB
5.5.1 UCB Profile
5.5.2 UCB Main Business
5.5.3 UCB Ankylosing Spondylitis Treatment Products, Services and Solutions
5.5.4 UCB Ankylosing Spondylitis Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 UCB Recent Developments
5.6 Boehringer Ingelheim
5.6.1 Boehringer Ingelheim Profile
5.6.2 Boehringer Ingelheim Main Business
5.6.3 Boehringer Ingelheim Ankylosing Spondylitis Treatment Products, Services and Solutions
5.6.4 Boehringer Ingelheim Ankylosing Spondylitis Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Boehringer Ingelheim Recent Developments
5.7 Johnson & Johnson
5.7.1 Johnson & Johnson Profile
5.7.2 Johnson & Johnson Main Business
5.7.3 Johnson & Johnson Ankylosing Spondylitis Treatment Products, Services and Solutions
5.7.4 Johnson & Johnson Ankylosing Spondylitis Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Johnson & Johnson Recent Developments
6 North America
6.1 North America Ankylosing Spondylitis Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Ankylosing Spondylitis Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Ankylosing Spondylitis Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Ankylosing Spondylitis Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Ankylosing Spondylitis Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Ankylosing Spondylitis Treatment Market Dynamics
11.1 Ankylosing Spondylitis Treatment Industry Trends
11.2 Ankylosing Spondylitis Treatment Market Drivers
11.3 Ankylosing Spondylitis Treatment Market Challenges
11.4 Ankylosing Spondylitis Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
